Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes
Objectives: The intracellular antibiotic efficiency of gentamicin-loaded microspheres in the context of Brucella-infected murine monocytes was examined in vitro with a view to developing improved therapies for the treatment of brucellosis. Methods: Biodegradable microspheres made of end-group cap...
| Main Authors: | , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
Oxford University Press
2011
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/19188 |
| _version_ | 1793400052708802560 |
|---|---|
| author | Prior, S. (Sandra) Gander, B. (Bruno) Lecaroz, M.C. (María Concepción) Irache, J.M. (Juan Manuel) Gamazo, C. (Carlos) |
| author_facet | Prior, S. (Sandra) Gander, B. (Bruno) Lecaroz, M.C. (María Concepción) Irache, J.M. (Juan Manuel) Gamazo, C. (Carlos) |
| author_sort | Prior, S. (Sandra) |
| collection | DSpace |
| description | Objectives: The intracellular antibiotic efficiency of gentamicin-loaded microspheres in the context of Brucella-infected murine monocytes was examined in vitro with a view to developing improved therapies for the treatment of brucellosis.
Methods: Biodegradable microspheres made of end-group capped and uncapped poly(lactide-co-glycolide) 50:50 (PLGA 50:50 and PLGA 50:50H) and containing gentamicin sulphate were used to target Brucella abortus-infected J774 monocyte-macrophages. The infected cells were treated with 15 µg of free or microencapsulated gentamicin and the efficacy of the treatments was measured after 24 h.
Results: The particle sizes were below 8 µm and in vitro release of gentamicin from the microspheres followed a continuous (PLGA 50:50H) or a multiphasic (PLGA 50:50) pattern over 50 days. Treatment with gentamicin microencapsulated into the end-group uncapped PLGA 50:50H microspheres, decreased significantly the number of intracellular bacteria (typically by 2 log10) in comparison with untreated infected cells. Addition of 2% poloxamer 188 to the microsphere dispersion medium further reduced the infection (3.5 log10). Opsonization of the particles with non-immune mouse serum had no effect on the antibacterial efficacy of the microspheres. End-group capped PLGA 50:50 type microspheres containing the antibiotic were less effective at reducing intracellular bacteria (∼1 log10 reduction), although addition of poloxamer 188 to the dispersion medium again enhanced their intracellular antibacterial activity. Placebo PLGA 50:50 and PLGA 50:50H microspheres had no bactericidal activity.
Conclusions: The results indicate that PLGA 50:50-microencapsulated gentamicin sulphate may be suitable for efficient drug targeting and delivery to reduce intracellular Brucella infections. |
| format | info:eu-repo/semantics/article |
| id | oai:dadun.unav.edu:10171-19188 |
| institution | Universidad de Navarra |
| language | eng |
| publishDate | 2011 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oai:dadun.unav.edu:10171-191882020-03-03T19:46:41Z Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes Prior, S. (Sandra) Gander, B. (Bruno) Lecaroz, M.C. (María Concepción) Irache, J.M. (Juan Manuel) Gamazo, C. (Carlos) Biodegradable microspheres Drug delivery systems Brucella-infected monocytes Objectives: The intracellular antibiotic efficiency of gentamicin-loaded microspheres in the context of Brucella-infected murine monocytes was examined in vitro with a view to developing improved therapies for the treatment of brucellosis. Methods: Biodegradable microspheres made of end-group capped and uncapped poly(lactide-co-glycolide) 50:50 (PLGA 50:50 and PLGA 50:50H) and containing gentamicin sulphate were used to target Brucella abortus-infected J774 monocyte-macrophages. The infected cells were treated with 15 µg of free or microencapsulated gentamicin and the efficacy of the treatments was measured after 24 h. Results: The particle sizes were below 8 µm and in vitro release of gentamicin from the microspheres followed a continuous (PLGA 50:50H) or a multiphasic (PLGA 50:50) pattern over 50 days. Treatment with gentamicin microencapsulated into the end-group uncapped PLGA 50:50H microspheres, decreased significantly the number of intracellular bacteria (typically by 2 log10) in comparison with untreated infected cells. Addition of 2% poloxamer 188 to the microsphere dispersion medium further reduced the infection (3.5 log10). Opsonization of the particles with non-immune mouse serum had no effect on the antibacterial efficacy of the microspheres. End-group capped PLGA 50:50 type microspheres containing the antibiotic were less effective at reducing intracellular bacteria (∼1 log10 reduction), although addition of poloxamer 188 to the dispersion medium again enhanced their intracellular antibacterial activity. Placebo PLGA 50:50 and PLGA 50:50H microspheres had no bactericidal activity. Conclusions: The results indicate that PLGA 50:50-microencapsulated gentamicin sulphate may be suitable for efficient drug targeting and delivery to reduce intracellular Brucella infections. 2011-10-22T17:18:04Z 2011-10-22T17:18:04Z 2004 info:eu-repo/semantics/article https://hdl.handle.net/10171/19188 eng info:eu-repo/semantics/openAccess application/pdf Oxford University Press |
| spellingShingle | Biodegradable microspheres Drug delivery systems Brucella-infected monocytes Prior, S. (Sandra) Gander, B. (Bruno) Lecaroz, M.C. (María Concepción) Irache, J.M. (Juan Manuel) Gamazo, C. (Carlos) Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title_full | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title_fullStr | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title_full_unstemmed | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title_short | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes |
| title_sort | gentamicin-loaded microspheres for reducing the intracellular brucella abortus load in infected monocytes |
| topic | Biodegradable microspheres Drug delivery systems Brucella-infected monocytes |
| url | https://hdl.handle.net/10171/19188 |
| work_keys_str_mv | AT priorssandra gentamicinloadedmicrospheresforreducingtheintracellularbrucellaabortusloadininfectedmonocytes AT ganderbbruno gentamicinloadedmicrospheresforreducingtheintracellularbrucellaabortusloadininfectedmonocytes AT lecarozmcmariaconcepcion gentamicinloadedmicrospheresforreducingtheintracellularbrucellaabortusloadininfectedmonocytes AT irachejmjuanmanuel gentamicinloadedmicrospheresforreducingtheintracellularbrucellaabortusloadininfectedmonocytes AT gamazoccarlos gentamicinloadedmicrospheresforreducingtheintracellularbrucellaabortusloadininfectedmonocytes |